ClinicalTrials.Veeva

Menu

Effect of Topical Lidocaine Spraying on the Vocal Cords Before Intubation During Robotic Surgery: a Randomized Controlled Trial

K

Kaohsiung Medical University

Status and phase

Not yet enrolling
Phase 4

Conditions

Lidocaine Spray
Intubation
Robotic Surgery

Treatments

Drug: Lidocaine %2 ampoule
Drug: Normal Saline (0.9% NaCl)

Study type

Interventional

Funder types

Other

Identifiers

NCT07154628
KMUHIRB-F(II)-20250221

Details and patient eligibility

About

Endotracheal intubation is a respiratory management technique used during general anesthesia. It is essential for certain surgical procedures as it ensures a secure airway for the patient.

However, during the placement of the endotracheal tube, the passage of the tube through the vocal cords can cause pain stimulation, leading to an increase in heart rate and blood pressure. Lidocaine reversibly blocks the conduction of nerve impulses along nerve fibers by preventing the movement of sodium ions across the nerve membrane. Topical application of lidocaine near the vocal cords before endotracheal tube placement may be a way to reduce the surgical pleth index and changes in vital signs (heart rate, blood pressure) caused by excessive endotracheal tube stimulation.

This study aims to investigate the benefit of topical spraying of lidocaine on the vocal cords before endotracheal tube placement during routine da Vinci surgery. The primary outcomes were the pharmacological effects of spraying either lidocaine or normal saline (control group) on the vocal cords. These included: post-intubation hypertension (defined as an increase in systolic blood pressure of more than 20% from baseline), changes in mean arterial pressure before and after intubation, and objective pain indices such as the Surgical Pleth Index. Secondary outcomes included post-intubation hypotension (defined as mean arterial pressure less than 70 mmHg), as well as postoperative complaints and severity of sore throat, pain on swallowing, and hoarseness.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA classification I~III
  • aged 18~69 y/o
  • BMI 18~35 kg/m2
  • scheduled for elective robotic surgery under general anesthesia

Exclusion criteria

  • Allergy or contraindication to lidocaine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

80 participants in 2 patient groups, including a placebo group

Lidocaine group
Active Comparator group
Description:
The group of patient will receive lidocaine spraying on vocal cord before intubation
Treatment:
Drug: Normal Saline (0.9% NaCl)
Control group
Placebo Comparator group
Description:
The group of patient will receive normal saline spraying on vocal cord before intubation
Treatment:
Drug: Lidocaine %2 ampoule

Trial contacts and locations

1

Loading...

Central trial contact

Yuh-Shyan Wu, MD; I-Cheng Lu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems